Pediatric Clinical Trials: Considerations for Enrollment and Retention
In this insightful paper we explore regulatory guidelines implemented to encourage pediatric drug development, specific study considerations particularly concerning safety and regulatory aspects (e.g., obtaining informed consent for adolescents), adapting endpoints, and the role of parents/caregivers and patient advocacy groups in patient recruitment and retention and throughout study lifespan.